English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Modern imaging techniques such as computed tomography (CT) and ultrasound (US) are in the majority of cases able to detect local and metastatic spread of malignancy. Increasingly, the requirement is for even more accurate pre-operative tumour staging to enable the use of new surgical techniques, neo-adjuvant therapies and, postoperatively, to enable detection of tumour recurrence on follow-up. Recent imaging research has focused on magnetic resonance imaging (MRI) for the detection of local tumour extension particularly for rectal tumours and on positron emission tomography (PET) and radioimmunoscintigraphy (RIS) for the detection of metastatic nodal and soft tissue disease. This article briefly describes these three imaging modalities and their role in primary staging, detection of hepatic metastases and local recurrence.

New techniques for imaging colorectal cancer: the use of MRI, PET and radioimmunoscintigraphy for primary staging and follow-up